We sought to examine mechanisms underlying nitroglycerin (NTG) tolerance and "cross-tolerance" to other nitrovasodilators. Rabbits were treated for 3 d with NTG patches (0.4 mg/h) and their aortic segments studied in organ chambers. Relaxations were examined after preconstriction with phenylephrine. In NTG tolerant rabbit aorta, relaxations to cGMP-dependent vasodilators such as NTG (45 +/- 6%), SIN-1 (69 +/- 7%), and acetylcholine (ACh, 64 +/- 5%) were attenuated vs. controls, (90 +/- 2, 94 +/- 3, and 89 +/- 2% respectively, P < 0.05 for all), while responses to the cAMP-dependent vasodilator forskolin remained unchanged. In tolerant aorta, endothelial removal markedly enhanced relaxations to NTG and SIN-1 (82 +/- 4 and 95 +/- 3%, respectively). Other studies were performed to determine how the endothelium enhances tolerance. Vascular steady state .-O2 levels (assessed by lucigenin chemiluminescence) was increased twofold in tolerant vs. control vessels with endothelium (0.31 +/- 0.01 vs. 0.61 +/- 0.01 nmol/mg per minute). This difference was less in vessels after denudation of the endothelium. Diphenylene iodonium, an inhibitor of flavoprotein containing oxidases, and Tiron a direct .-O2 scavenger normalized .-O2 levels. In contrast, oxypurinol (1 mM) an inhibitor of xanthine oxidase, rotenone (50 microM) an inhibitor of mitochondrial electron transport and NG-nitro-L-arginine (100 microM) an inhibitor of nitric oxide synthase did not affect the chemiluminescence signals from NTG-tolerant aortas. Pretreatment of tolerant aorta with liposome-entrapped, pH sensitive superoxide dismutase (600 U/ml) significantly enhanced maximal relaxation in response to NTG, SIN-1, and ACh, and effectively reduced chemiluminescence signals. These studies show that continuous NTG treatment is associated with increased vascular .-O2-production and consequent inhibition of NO. mediated vasorelaxation produced by both exogenous and endogenous nitrovasodilators.
T Münzel, H Sayegh, B A Freeman, M M Tarpey, D G Harrison
Title and authors | Publication | Year |
---|---|---|
Cardiac NO signalling in the metabolic syndrome: Heart, NO and metabolic syndrome
O Pechánová, ZV Varga, M Cebová, Z Giricz, P Pacher, P Ferdinandy |
British Journal of Pharmacology | 2014 |
Organic nitrates: Update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction
T Münzel, S Steven, A Daiber |
Vascular Pharmacology | 2014 |
Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation:
S Chrissobolis, GR Drummond, FM Faraci, CG Sobey |
Journal of Hypertension | 2014 |
Aging Aggravates Nitrate-Mediated ROS/RNS Changes
Q Fan, L Chen, S Cheng, F Li, WB Lau, LF Wang, JH Liu |
Oxidative medicine and cellular longevity | 2014 |
Role of the Lipid Peroxidation Product, 4-Hydroxynonenal, in the Development of Nitrate Tolerance
Y D’Souza, T Kawamoto, BM Bennett |
Chemical Research in Toxicology | 2014 |
Reliable evaluation of molecular structure of methyl 3-O-nitro-α-d-glucopyranoside and its intermediates by means of solid-state NMR spectroscopy and DFT optimization in the absence of appropriate crystallographic data
T Gubica, Ł Szeleszczuk, DM Pisklak, DK Stępień, MK Cyrański, M Kańska |
Tetrahedron | 2014 |
Challenges with Nitrate Therapy and Nitrate Tolerance: Prevalence, Prevention, and Clinical Relevance
U Thadani |
American Journal Cardiovascular Drugs | 2014 |
Enhancing vascular relaxing effects of nitric oxide-donor ruthenium complexes
M Paulo, TM Banin, FA de Andrade, LM Bendhack |
Future Medicinal Chemistry | 2014 |